|
聯康生物科技集團有限公司, 00690.HK - 綜合損益表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2014-03 |
2013-03 |
2012-03 |
2011-03 |
2010-03 |
2009-03 |
2008-03 |
2007-03 |
2006-03 |
2005-03 |
營業額 |
440,316 |
353,405 |
208,776 |
209,449 |
135,258 |
156,477 |
146,489 |
123,364 |
91,793 |
102,624 |
83,333 |
57,026 |
76,764 |
148,286 |
526,270 |
869,946 |
259,519 |
94,949 |
134,270 |
經營溢利 |
46,137 |
-39,556 |
-60,051 |
-5,293 |
-115,483 |
-103,728 |
-46,782 |
-42,195 |
-40,621 |
-359,094 |
-61,090 |
-96,586 |
-177,582 |
-447,130 |
-454,246 |
336,158 |
122,536 |
-47,073 |
-137 |
非經營/ 特殊項目 |
-2,850 |
19,544 |
-10,890 |
-8,344 |
-8,550 |
-6,864 |
-7,038 |
-9,991 |
0 |
0 |
0 |
0 |
-1,938 |
-2,455 |
-967 |
-1,745 |
-4,726 |
1,359 |
0 |
聯營公司 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-5,044 |
-422 |
-1,365 |
497 |
-638 |
-3,230 |
-886 |
1 |
0 |
0 |
0 |
0 |
除稅前經營溢利 |
43,287 |
-20,012 |
-70,941 |
5,140 |
-138,433 |
-278,297 |
-53,820 |
-57,230 |
-41,043 |
-364,197 |
-68,263 |
-102,408 |
-182,750 |
-450,471 |
-455,212 |
334,413 |
117,810 |
-45,714 |
-137 |
稅項 |
4,775 |
-421 |
378 |
2,681 |
134 |
1,012 |
1,907 |
2,569 |
1,391 |
1,933 |
1,045 |
456 |
2,406 |
4,182 |
53,111 |
139,134 |
55,665 |
-3,554 |
87 |
少數股東權益 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-6 |
286 |
663 |
股東應占溢利 |
38,512 |
-19,591 |
-71,319 |
2,459 |
-138,567 |
-279,309 |
-55,727 |
-59,799 |
-42,434 |
-366,130 |
-69,308 |
-102,864 |
-185,156 |
-454,653 |
-508,323 |
198,380 |
60,322 |
-42,446 |
-887 |
貨幣 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
單位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
主要項目 |
折舊 |
17,546 |
20,850 |
20,920 |
21,487 |
20,920 |
23,866 |
23,595 |
31,715 |
37,226 |
64,143 |
61,327 |
64,563 |
35,318 |
44,534 |
53,614 |
33,600 |
20,591 |
9,864 |
10,795 |
利息 |
376 |
477 |
73 |
749 |
247 |
177 |
497 |
0 |
0 |
3,738 |
7,670 |
5,184 |
1,683 |
2,323 |
967 |
1,745 |
6,847 |
4,130 |
4,483 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
11.03 |
2.1 |
-0.53 |
52.16 |
-0.1 |
-0.36 |
-3.54 |
-4.49 |
-3.39 |
-0.53 |
-1.53 |
|
|
|
|
41.22 |
50.08 |
|
|
營業額增長(%) |
24.59 |
69.27 |
-0.32 |
54.85 |
-13.56 |
6.82 |
18.75 |
34.39 |
0.0 |
23.15 |
46.13 |
-25.71 |
-48.23 |
-71.82 |
-39.51 |
155.2 |
259.03 |
-29.29 |
-8.18 |
股東應占溢利增長(%) |
0.0 |
72.53 |
0.0 |
0.0 |
50.39 |
-401.21 |
6.81 |
-40.92 |
0.0 |
428.27 |
-32.62 |
|
|
|
|
228.87 |
|
|
|
核數師意見 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
2 |
1 |
1 |
1 |
1 |
1 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|